{"disease":{"id":"locally-advanced-rectal-cancer","name":"locally advanced rectal cancer"},"drugs":{"marketed":[{"drug_id":"capecitabine","indication_name":"Perioperative treatment of locally advanced rectal cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xeloda","generic_name":"capecitabine","company_name":"Cheplapharm","drug_phase":"marketed","molecular_target":"Thymidylate synthase","drug_class":"Nucleoside Metabolic Inhibitor [EPC]","quality_score":67,"revenue":null,"mechanism":"Xeloda works by inhibiting the enzyme thymidylate synthase, which is necessary for DNA synthesis in cancer cells."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07351708","title":"Development and Validation of a Post-operative Risk Of Local Recurrence Model Integrating Serology and Evalution (PROMISE) in Local Advanced Rectal Cancer Receiving Neoadjuvant Therapy: a Multicenter Study","phase":"","overall_status":"COMPLETED","enrollment_count":2315,"lead_sponsor_name":"Cai Zerong","has_results":false},{"nct_id":"NCT06783491","title":"Efficacy of the Use of Neoadjuvant With/Without Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Advanced Colon Cancer","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":1083,"lead_sponsor_name":"Maimónides Biomedical Research Institute of Córdoba","has_results":false},{"nct_id":"NCT04948762","title":"A Contemporary Review of Surgical Approaches in Pelvic Exenterative Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"St Vincent's University Hospital, Ireland","has_results":false},{"nct_id":"NCT00911170","title":"PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":847,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT05610163","title":"Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":783,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":false},{"nct_id":"NCT06028724","title":"A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)","phase":"","overall_status":"RECRUITING","enrollment_count":782,"lead_sponsor_name":"Centro di Riferimento Oncologico - Aviano","has_results":false},{"nct_id":"NCT05646511","title":"TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":608,"lead_sponsor_name":"National Cancer Center Hospital East","has_results":false},{"nct_id":"NCT05919264","title":"FOG-001 in Locally Advanced or Metastatic Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":595,"lead_sponsor_name":"Parabilis Medicines, Inc.","has_results":false},{"nct_id":"NCT03238885","title":"Predicting Pathological Complete Response of Rectal Cancer With Magnetic Resonance(MR) Radiomics","phase":"","overall_status":"COMPLETED","enrollment_count":538,"lead_sponsor_name":"Sun Ying-Shi","has_results":false},{"nct_id":"NCT03149978","title":"Tumor Response Prediction in Neoadjuvant Chemoradiation of Locally Advanced Rectal Cancer Using Metabonomics Analysis","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Zhu Ji","has_results":false},{"nct_id":"NCT05581004","title":"A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Genentech, Inc.","has_results":false},{"nct_id":"NCT07277842","title":"PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":382,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07074353","title":"Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":360,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT02874885","title":"Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":341,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06293612","title":"Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":302,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT07381777","title":"XELOX Plus DoSTARlimab Versus XELOX Alone as Consolidation Treatment After Standard Chemoradiation in pMMR/MSS or MSI-Low Locally Advanced Rectal Cancer (LARC) Patients","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":270,"lead_sponsor_name":"Gruppo Oncologico Italiano di Ricerca Clinica","has_results":false},{"nct_id":"NCT07346248","title":"Postoperative Complications After Neoadjuvant Chemoradiotherapy or Short-course Radiotherapy and Total Neoadjuvant Treatment: a Multicentric Retrospective Cohort Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":266,"lead_sponsor_name":"Istituto Clinico Humanitas","has_results":false},{"nct_id":"NCT05893667","title":"Evaluation of Inflammatory Markers in LARC Patients","phase":"","overall_status":"COMPLETED","enrollment_count":245,"lead_sponsor_name":"Hospital Pedro Hispano","has_results":false},{"nct_id":"NCT07040098","title":"Optimizing Immunotherapy Combined With Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":228,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT04423965","title":"A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":220,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT04394598","title":"A Study of Chinese Herbal Compound Dendrobium Huoshanense Granules in NCRT for Patients With Locally Advanced Rectal Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":210,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06281405","title":"CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":192,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05245474","title":"Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":186,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT07020247","title":"Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":184,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT05079438","title":"Dendrobium Huoshanense Suppository in Rectal Cancer","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":168,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT03702985","title":"Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":160,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT07150949","title":"Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":138,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT04518280","title":"Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT07469306","title":"Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":130,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT07448077","title":"Short-course Radiotherapy in TNT Combined With Enlonstobart for pMMR LARC","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":128,"lead_sponsor_name":"Hebei Medical University Fourth Hospital","has_results":false},{"nct_id":"NCT05086627","title":"Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Hebei Medical University Fourth Hospital","has_results":false},{"nct_id":"NCT06864013","title":"SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":116,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT07511413","title":"GALENOS 1 in Head and Neck, Lung, and Rectal Cancer Patients","phase":"","overall_status":"RECRUITING","enrollment_count":110,"lead_sponsor_name":"Fondazione del Piemonte per l'Oncologia","has_results":false},{"nct_id":"NCT05487248","title":"A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":103,"lead_sponsor_name":"Jules Bordet Institute","has_results":false},{"nct_id":"NCT05845268","title":"Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":102,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT06375434","title":"Correlation Between Gut Microbiota and Radiosensitivity of Rectal Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Jing-kun Liu","has_results":false},{"nct_id":"NCT05507112","title":"TIME in Immunotherapy Combined With nCRT for Rectal Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT02151019","title":"Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":94,"lead_sponsor_name":"Cancer Trials Ireland","has_results":false},{"nct_id":"NCT07049627","title":"AI-Based Prediction of Pathological Response in Rectal Cancer Patients Receiving Total Neoadjuvant Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":93,"lead_sponsor_name":"Ankara Etlik City Hospital","has_results":false},{"nct_id":"NCT07057089","title":"Involved-field Radiotherapy-TNT Combined With PD-1 Inhibitor for pMMR Locally Advanced Rectal Cancer (Neo-Field I)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Hebei Medical University Fourth Hospital","has_results":false},{"nct_id":"NCT07005570","title":"Short-course Radiotherapy Followed by Sequential Chemotherapy With or Without PD-1 Monoclonal Antibody and Bevacizumab as Total Neoadjuvant Therapy in pMMR/MSS Locally Advanced Rectal Cancer （SPARK）","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":86,"lead_sponsor_name":"Dechang Diao","has_results":false},{"nct_id":"NCT07410676","title":"EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":83,"lead_sponsor_name":"Essen Biotech","has_results":false},{"nct_id":"NCT06440005","title":"A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Angiex, Inc.","has_results":false},{"nct_id":"NCT05300269","title":"SHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":73,"lead_sponsor_name":"Suzhou Suncadia Biopharmaceuticals Co., Ltd.","has_results":false},{"nct_id":"NCT07248020","title":"A Phase II Single-Arm Study of High-Bioavailability Curcumin as Neoadjuvant Chemoradiotherapy in Mid-to-Low Rectal Cancer: Integrated Clinical and Translational Analysis of Tumor Tissue","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":72,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT07243938","title":"Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":70,"lead_sponsor_name":"Tao Zhang","has_results":false},{"nct_id":"NCT06894797","title":"Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.","phase":"NA","overall_status":"RECRUITING","enrollment_count":68,"lead_sponsor_name":"Peking University Cancer Hospital & Institute","has_results":false},{"nct_id":"NCT07175636","title":"QL1706 With Short-Course Radiotherapy and Chemotherapy for MSS Rectal Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":66,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05253846","title":"Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":63,"lead_sponsor_name":"Gruppo Oncologico del Nord-Ovest","has_results":false},{"nct_id":"NCT04815694","title":"THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":63,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}